Glaser, R., & Dimitrakakis, C. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230-234.
DeRosa, A. (2025). Testosterone: Strong Enough for a Man, but Made for a Woman. Medical Research Archives, 13(11).
The Pellet Method is a practical training program for clinicians who want more confidence, clarity, and skill in caring for women through perimenopause, menopause including breast cancer survivors.
Thoughtful, evidence-aware training for practitioners ready to expand their approach to hormone care and better serve the women counting on them.
Founded by Dr. W, the program blends clinical excellence and hands-on skill development.
“Subcutaneous testosterone implant therapy relieves symptoms of hormone deficiency in women with and without breast cancer, improves their quality of life, and maintains overall health and well-being. Testosterone does not increase and may lower the risk of breast cancer.” — Glaser R, Dimitrakakis C. Testosterone Implant Therapy: Rationale, Experience, Evidence.
Peer-reviewed data proves that testosterone is the most abundant biologically active sex hormone in a woman’s body.
At The Pellet Method, our goal is for providers to leave training with a fundamentally different understanding of hormone replacement therapy. Pellets are not simply another form of hormone replacement—they are a powerful clinical tool that can meaningfully elevate patient outcomes across a wide range of conditions.
When dosed precisely and delivered correctly, hormone pellets support systemic regulation that extends beyond symptom management. They can play a role in addressing metabolic dysfunction, cognitive and mood disorders, bone health, sexual health, and chronic fatigue states, while offering patients consistent delivery, improved adherence, and long-term stability. Our training is designed to help providers think beyond protocols and toward whole-patient, disease-aware care.
By the end of training, providers understand not just how to place pellets, but when and why they elevate patient care.
Hormone pellet therapy is an outcomes-driven component of modern, evidence-informed medicine.
“Testosterone and/or testosterone/anastrozole pellet implants significantly reduced the incidence of breast cancer in pre- and post-menopausal women… demonstrating the benefits of testosterone therapy in reducing the incidence of invasive breast cancer.”
— Glaser RL, et al. The Dayton Prospective Breast Cancer Prevention Cohort Study.
“Endogenous androgens normally inhibit mammary epithelial proliferation and thereby may protect against breast cancer… the addition of a small, physiological dose of testosterone to standard therapy almost completely attenuates estrogen-induced increases in cell proliferation.” — Dimitrakakis C, et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast.
